Mallinckrodt | search
Click here to view Mallinckrodt news from 60+ newspapers.
Bookmark or Share- Mallinckrodt Receives U.S. FDA Approval for Terlivaz® (terlipressin ...DUBLIN, Sept. 14, 2022 /PRNewswire/ -- Mallinckrodt plc (OTCMKTS: MNKPF), a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) approved Terlivaz ® (terlipressin) for injection. Terlivaz is the first and only FDA-approved product indicated to improve kidney function in adults with ...
- Mallinckrodt Announces U.S. FDA Approval of Supplemental New Drug ...DUBLIN, March 1, 2024 /PRNewswire/ -- Mallinckrodt plc, a global specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Mallinckrodt's supplemental New Drug Application (sNDA) for the Acthar ® Gel (repository corticotropin injection) Single-Dose Pre-filled SelfJect™ Injector (herein ...
- Mallinckrodt Pharmaceuticals | Global Specialty Pharmaceutical Company ...Our Products. Building on our heritage and distinctive capabilities, our world-class development and formulation expertise bring medical solutions to the marketplace. As a global specialty pharmaceutical company, Mallinckrodt has been making the complex simple for more than 150 years. Visit the website to learn more.
- Our Story | Mallinckrodt PharmaceuticalsMallinckrodt Pharmaceuticals spins off from Covidien, becoming an independent, $2 billion public company that develops, manufactures, markets, and distributes specialty pharmaceutical products and diagnostic imaging agents. Receives FDA approval for two new drugs.
- Our Products | Mallinckrodt PharmaceuticalsMallinckrodt has a diverse portfolio of branded products available across a broad range of indications and a broad line of speciality generics. Visit our website to learn about our product offerings.
More
